Could a blood pressure drug slow Alzheimer's? new trial aims to find out

NCT ID NCT06362707

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 2 trial tests whether fasudil, a drug already used in Japan and China for brain blood vessel spasms, can improve memory and brain function in people with early Alzheimer's disease. Two hundred participants will receive either fasudil or a placebo for 12 months, with regular cognitive tests and brain scans to measure effects. The goal is to see if fasudil can slow the decline in thinking skills and brain metabolism.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fasudil (a drug approved in Japan and China for vasospasms, now being tested for Alzheimer's)
What this could lead to
If it works, this could point toward a treatment that slows memory loss and brain decline in early Alzheimer's disease.
What could go wrong
This is an early Phase 2 trial with only 200 participants, so results may not apply to everyone. The drug is not yet proven for Alzheimer's, and side effects are still being studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Akershus Hospital:

    NOT_YET_RECRUITING

    Oslo, Oslo, Norway

  • Haraldsplass Deaconess Hospital

    ENROLLING_BY_INVITATION

    Bergen, Vestland, Norway

  • Haugesund Hospital

    NOT_YET_RECRUITING

    Haugesund, Rogaland, Norway

  • St. Olavs Hospital:

    NOT_YET_RECRUITING

    Trondheim, Trøndelag, Norway

  • Stavanger University Hospital

    RECRUITING

    Stavanger, Rogaland, Norway

  • University Hospital of North Norway

    NOT_YET_RECRUITING

    Tromsø, Nordland, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.